[1]
“Pathogenetic mechanism of macular edema during a treatment with ibrutinib: a case presentation”., Mediterr J Hematol Infect Dis, vol. 18, no. 1, p. e2026009, Jan. 2026, doi: 10.4084/MJHID.2026.009.